Clinical Trials Logo

Clinical Trial Summary

Twenty patients of mild to moderate degree of arsenical palmer keratosis will be treated with garlic oil capsule orally for 12 weeks to examine its effectiveness in reducing body arsenic load and clinical symptoms. Similar treatment with similar number of arsenic exposed controls and healthy volunteers will be included for comparison.


Clinical Trial Description

Thousands of Bangladeshi are suffering from arsenic-induced keratosis affecting palms and soles. Palmer keratosis, particularly in young female, affects the socioeconomic condition. Till today there is no effective treatment.

Twenty patients of mild to moderate degree of arsenical palmer keratosis will be treated with garlic oil in soft capsule (10 mg/day) orally for 12 weeks. Similar treatment will be given to 20 arsenic exposed controls and 20 healthy volunteers for comparison. The aim of this study is to examine the effectiveness of oral administration of garlic oil to reduce body arsenic load and clinical symptoms of arsenical palmer keratosis. ;


Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01748669
Study type Interventional
Source Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Contact
Status Completed
Phase Phase 2
Start date October 2011
Completion date July 2012

See also
  Status Clinical Trial Phase
Completed NCT01743066 - Vitamin E Level in Buccal Cells of Arsenicosis Patients N/A
Completed NCT02468518 - Effect of Vitamin E on Skin Aerobic Bacteria in Palmar Arsenical Keratosis Phase 2
Completed NCT02352987 - Effect of Neem Extract, Propylene Glycol and Salicylic Acid Combination in the Treatment of Arsenical Palmar Keratosis Phase 2
Completed NCT02908581 - Effect of Iron and Folic Acid on Skin Fungal Pattern in Patients With Arsenicosis Phase 2
Completed NCT03127657 - Effect of Cock's Comb Extract in the Treatment of Arsenical Skin Lesion Phase 2
Completed NCT01726426 - Modulation of Anaerobic Gut Bacteria of Arsenicosis Patients by Probiotics N/A